A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
Status:
Recruiting
Trial end date:
2023-05-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the antiviral activity of JNJ-64281802 versus
placebo in terms of reduction of dengue virus (DENV) ribonucleic acid (RNA) in primary DENV
infection.